全文获取类型
收费全文 | 29310篇 |
免费 | 3490篇 |
国内免费 | 1025篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 1141篇 |
妇产科学 | 138篇 |
基础医学 | 2092篇 |
口腔科学 | 94篇 |
临床医学 | 2819篇 |
内科学 | 3903篇 |
皮肤病学 | 186篇 |
神经病学 | 194篇 |
特种医学 | 670篇 |
外国民族医学 | 1篇 |
外科学 | 11535篇 |
综合类 | 4455篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 874篇 |
眼科学 | 26篇 |
药学 | 2348篇 |
14篇 | |
中国医学 | 2751篇 |
肿瘤学 | 563篇 |
出版年
2024年 | 95篇 |
2023年 | 770篇 |
2022年 | 870篇 |
2021年 | 2129篇 |
2020年 | 1530篇 |
2019年 | 1628篇 |
2018年 | 1479篇 |
2017年 | 1450篇 |
2016年 | 1451篇 |
2015年 | 1448篇 |
2014年 | 2265篇 |
2013年 | 2306篇 |
2012年 | 1569篇 |
2011年 | 1762篇 |
2010年 | 1468篇 |
2009年 | 1306篇 |
2008年 | 1314篇 |
2007年 | 1196篇 |
2006年 | 1102篇 |
2005年 | 934篇 |
2004年 | 805篇 |
2003年 | 681篇 |
2002年 | 579篇 |
2001年 | 544篇 |
2000年 | 362篇 |
1999年 | 303篇 |
1998年 | 265篇 |
1997年 | 213篇 |
1996年 | 231篇 |
1995年 | 201篇 |
1994年 | 188篇 |
1993年 | 150篇 |
1992年 | 149篇 |
1991年 | 143篇 |
1990年 | 106篇 |
1989年 | 114篇 |
1988年 | 79篇 |
1987年 | 81篇 |
1986年 | 65篇 |
1985年 | 65篇 |
1984年 | 71篇 |
1983年 | 39篇 |
1982年 | 52篇 |
1981年 | 49篇 |
1980年 | 33篇 |
1979年 | 45篇 |
1978年 | 33篇 |
1977年 | 29篇 |
1976年 | 26篇 |
1975年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
71.
72.
两种艾灸法对二肾一夹型高血压大鼠血压和血管内皮细胞内分泌功能的影响 总被引:4,自引:0,他引:4
目的:应用两种艾灸疗法治疗两肾一夹肾血管性高血压大鼠(2K1C-RHR),评价这两种艾灸疗法的降压作用,并对其降压机理作初步的探讨。方法:建立2K1C-RHR模型,并将其随机分为六组:灸法Ⅰ组(百会、神阙、足三里)、灸法Ⅱ组(关元、涌泉、足三里)、卡托普利组、灸法Ⅰ+卡托普利组、灸法Ⅱ+卡托普利组、高血压对照组,另设正常对照组。经过10天治疗后,测量血压,并测定血浆中内皮素(ET)、一氧化氮(NO)。结果:高血压对照组的收缩压(SBP)、舒张压(DBP)明显高于正常对照组,各治疗组的SBP、DBP明显低于高血压对照组(P<0.01),各治疗组间则没有明显差异(P>0.05)。血浆NO含量各组间没有明显差异(P>0.05)。各治疗组与正常对照组的血浆中ET含量明显低于高血压对照组(P<0.01)。各治疗组ET/NO比值接近正常对照组(P>0.05)且明显低于高血压对照组(P>0.05)。结论:两种艾灸疗法有良好的降压作用,其降压机理与及纠正ET与NO的失衡状态有关。 相似文献
73.
李剑锋 《世界中西医结合杂志》2008,3(3):165-166
肠易激综合征(IBS)是一组持续存在或反复发作的临床症候群,主要症状有腹痛、腹胀、排便习惯改变和大便性状异常、黏液便等,经检查排除可引起这些症状的器质性疾病。临床分为肝木乘脾型腹泻、脾胃虚弱型腹泻、脾肾阳虚型腹泻、肝郁脾虚型便秘四型,根据临床辨证分别施以不同治法,不同方药治疗,有显著疗效。同时,教育患者平时养成良好的饮食卫生习惯,不饮生水,不食生冷瓜果,忌食辛辣、油腻、肥厚之品,保持心情舒畅,怡情悦志,注意保暖,可加强疗效,防止复发。 相似文献
74.
H. S. Pollinger M. D. Stegall J. M. Gloor S. B. Moore S. R. Degoey N. A. Ploeger W. D. Park H. S. Pollinger M. D. Stegall J. M. Gloor S. B. Moore S. R. Degoey N. A. Ploeger W. D. Park 《American journal of transplantation》2007,7(4):857-863
The immunologic risk associated with donor-specific antibodies (DSA) against Class II human leukocyte antigens (HLA) in kidney transplant (KTx) recipients is unclear. The aim of this study was to determine the outcome of KTx when DSA was detected only against HLA Class II. To isolate the impact of anti-Class II DSA, we retrospectively analyzed 12 KTx recipients who at baseline had a positive B-cell flow cytometric crossmatch (FXM) and a negative T-cell FXM. Using alloantibody specification analysis, 58.3% (7/12) had DSA against donor Class II and 41.7% had no demonstrable DSA. Biopsy-proven AMR occurred in 57% (4/7) in the Class II(+) group and 0% in the Class II(-) group (p > 0.05). Peritubular capillaries stained positive for C4d in 86% (6/7) of the Class II(+) patients and in 40% (2/5) of the Class II(-) patients (p > 0.05). One patient in the Class II(+) group lost their graft at 3 months to accelerated transplant glomerulopathy, while all other grafts were functioning 3-37 months posttransplant despite the persistence of anti-Class II DSA. We conclude that KTx recipients with clearly defined anti-Class II DSA are at risk for humoral rejection suggesting that desensitization and/or close posttransplant monitoring may be needed to prevent AMR. 相似文献
75.
76.
F.-P. Tillmann M. Jäger D. Blondin D. Schooldermann A. Voiculescu C. Sucker B. Grabensee R. Krauspe G. R. Hetzel 《American journal of transplantation》2007,7(3):667-671
The purpose of this study was to investigate the application of intravenous iloprost as a novel therapy for the treatment of post-transplant distal limb syndrome (PTDLS). PTDLS is a benign but disabling complication in the first year after renal transplantation. It is characterized by bilateral, often incapacitating pain in the feet and or knees on motion and a significant rise in alkaline phosphatase levels on laboratory evaluation. On MRI, bone marrow edema of the affected bone regions can be demonstrated. PTDLS differs from steroid induced osteonecrosis of the hip in terms of localization, an average cumulative steroid dosage within expected limits, and a benign outcome, as PTDLS does not progress to overt cell necrosis. From August 2003 to April 2005 we treated 10 patients with MRI-proven diagnosis of PTDLS following a standardized regimen of intravenous iloprost over 5 days. Iloprost led to prompt pain relief measured on a visual analogous scale (VAS) ranging from 1 to 10 (5.6 +/- 1.5 before vs. 2.1 +/- 1.3 after treatment, p = 0.0004). PTDLS represents a benign but disabling complication following renal transplantation. Intravenous iloprost might be a promising therapeutic concept leading to a quick relief of symptoms without relevant side effects. 相似文献
77.
目的研究假性血管血友病因子(vWF)及血小板膜糖蛋白Ib(GPIb)在慢性肾脏疾病(CKD)不同阶段的变化及意义。方法87例患者按病因及CKD不同阶段分为5组,A组:CKD1期,肾小球肾炎组,17例;B组:CKD1期,原发性肾病综合征组,14例;C组:CKD1期,继发性肾病组,18例;D组:CKD2~4期,慢性肾衰组,18例;E组:CKD5期,慢性肾衰透析组,20例。酶联免疫吸附检测法测定GPIb、双抗体夹心固相酶免疫测定血浆vWF。结果vWF、GPIb在A、B、C、D、E组均明显增高,以B、C组尤为突出;与凝血状况正相关。结论vWF水平可同时反应内皮细胞受损及凝血状态,在肾小球疾病发展中可能有重要意义。 相似文献
78.
79.
目的:探讨射频肝肿瘤灭活术对肾脏的影响。方法:22只植有VX2肝肿瘤的新西兰白种兔随机分为2组:A组(治疗组n=15),开腹后对肝肿瘤进行射频治疗,功率为30w,持续3~4 min。B组(对照组n=7),开腹后关腹,不作任何治疗。分别于术前、术后3、7、14天观察血中尿素氮(BUN)、肌酐(Cr)、尿中红细胞和病理变化。结果:A组术后3天尿素氮升高,肌酐升高,尿中红细胞增多,肾小管上皮发生颗粒样变性。术后7天肌酐恢复正常水平,14天后各项指标均恢复正常。B组无明显变化。结论:射频肝肿瘤灭活术对肾脏有影响作用,但是为可逆性暂时性的损害。 相似文献
80.
Raja Kandaswamy J. Keith Melancon Ty Dunn Miguel Tan Vincent Casingal Abhinav Humar William D. Payne Rainer W. G. Gruessner David L. Dunn John S. Najarian David E. R. Sutherland Kristen J. Gillingham Arthur J. Matas 《American journal of transplantation》2005,5(6):1529-1536
We compared three maintenance immunosuppressive regimens in a rapid discontinuation of prednisone protocol. From March 1, 2001, through December 31, 2003, 239 first and second kidney transplant recipients (166 LD; 73 DD) were randomized. All recipients were treated with Thymoglobulin; all received steroids intraoperatively and for 5 days postoperatively. Randomization was to cyclosporine-mycophenolate mofetil (n = 85); high-level tacrolimus (TAC) (8-12 ng/mL)-low-level sirolimus (SRL) (3-7 ng/mL) (n = 72); or low-level TAC (3-7 ng/mL)-high-level SRL (8-12 ng/mL) (n = 82). We found no difference at 24 months between groups in patient, graft, death-censored graft, or acute rejection-free graft survival, or in kidney function. Wound complications were more common in SRL-treated recipients (p = 0.02); we found no other differences between groups in complication rates. Our data suggest that excellent patient and graft survival and low rejection rates can be obtained using a variety of maintenance protocols without prednisone. 相似文献